At 24 months, endocrine therapy appeared to have a more negative effect on HRQOL as measured by the global health status (GHS ...
It’s been long known that women with BRCA1 and BRCA2 gene mutations are at higher risk for breast and ovarian cancer. More ...
Groundbreaking research presented at the San Antonio Breast Cancer Symposium suggests thousands of women with early-stage ...
Women with a type of low-risk cancer might not have to rush aggressive treatment, doctors say.
Tecentriq plus chemotherapy did not improve event-free survival in triple-negative breast cancer but increased rate of ...
A new screening method that combines laser analysis with a type of AI is the first of its kind to identify patients in the earliest stage of breast cancer, a study suggests.
Patients with early-stage, node-negative, hormone receptor (HR)-positive, HER2- negative breast cancer who have a high risk ...
Over half of breast cancer survivors (57.2%) report oncologist-led care more than 5 years posttreatment, while only 22.4% ...
The Barbara Cares Foundation, a Fort Worth-based nonprofit, has $10,000 of funding to give out by the end of the year.